BREAKING NEWS ON EARLY STAGE ALZHEIMER'S TREATMENT
The U.S. Food and Drug Administration (FDA) has moved to grant traditional approval of Lequembi® (lecanemab).
What does this mean for you?
Read the Full Statement from the Alzheimer's Association Here
Click Here to listen to the listen to the newest Dementia Matters podcast episode on 'Putting Lecanemab into Practice: A Clinician's Perspective On The New Alzheimer's Treatment'
|